Carson Wealth (CWM LLC)
RXRX icon

Carson Wealth (CWM LLC)’s Recursion Pharmaceuticals RXRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11K Buy
+20,000
New +$77.3K ﹤0.01% 4739

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RXRX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Recursion Pharmaceuticals (RXRX) stake by 19% in Q1 2026, selling an estimated $18.6K and leaving 21,203 shares worth $65.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3617.

Carson Wealth (CWM LLC) first reported a position in RXRX in Q2 2021 and has held it in 18 quarters since. The position peaked at $127K in Q1 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 21,203 shares of Recursion Pharmaceuticals worth $65.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 4,815 Recursion Pharmaceuticals shares in Q1 2026, an estimated $18.6K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3617 holding.
  • Carson Wealth (CWM LLC) first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Recursion Pharmaceuticals position peaked at $127K in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.